Advertisement
Screener

CABALETTA BIO, INC. (CABA) Deferred Tax Assets, Operating Loss Carryforwards, Foreign

2.8 / 5 stars · 68/120 Roast Me

CABALETTA BIO, INC. Deferred Tax Assets, Operating Loss Carryforwards, Foreign

CABALETTA BIO, INC. (CABA) had Deferred Tax Assets, Operating Loss Carryforwards, Foreign of $319.89 million as of 2025-12-31, per its 10-K filed 2026-03-23.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components

us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign · last filed 2026-03-23

  • 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $319.89M.
Period endDeferred Tax Assets, Operating Loss Carryforwards, Foreign
2025-12-31$319.89M
10-K · filed 2026-03-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
AGENUS INC (AGEN)United States$0.383B1.41
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02